Technetium-99m hexamethyl propylene amine oxime-labeled leukocyte scintigraphy at three different times in active ulcerative colitis: comparison with colonoscopy and clinico-biochemical parameters in the assessment of disease extension and severity

[1]  A. Kornbluth,et al.  Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee , 2010, The American Journal of Gastroenterology.

[2]  S. Perlman,et al.  Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease , 2007, Inflammatory bowel diseases.

[3]  J. Belaiche,et al.  Noninvasive Assessment of Crohn's Disease Intestinal Lesions with 18F-FDG PET/CT , 2007, Journal of Nuclear Medicine.

[4]  A. Alavi,et al.  Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. , 2006, The Journal of arthroplasty.

[5]  S. Goldman,et al.  Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  K. Nichols,et al.  PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection. , 2006, Radiology.

[7]  M. Sans,et al.  Optimization of Technetium-99m-HMPAO Leukocyte Scintigraphy in Evaluation of Active Inflammatory Bowel Disease , 2000, Digestive Diseases and Sciences.

[8]  E. Pauwels,et al.  Inflammatory Bowel Disease Activity Assessment Using Technetium-99m-HMPAO Leukocytes , 1997, Digestive Diseases and Sciences.

[9]  F. Nagy,et al.  Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease , 1993, European Journal of Nuclear Medicine.

[10]  I. Fogelman,et al.  Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease , 1993, European Journal of Nuclear Medicine.

[11]  E. Lantto,et al.  Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease , 2004, European Journal of Nuclear Medicine.

[12]  M. Charron.  Inflammatory bowel disease activity assessment with biologic markers and 99mTc-WBC scintigraphy: are there different trends in ileitis versus colitis? , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  M. Phelps,et al.  Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[14]  L. Mortelmans,et al.  Tc-99m HMPAO White Blood Cell Scintigraphy in the Assessment of the Extent and Severity of an Acute Exacerbation of Ulcerative Colitis , 2001, Clinical nuclear medicine.

[15]  E. Prats,et al.  Clinical applications of radiolabeled blood elements in inflammatory bowel disease. , 1999, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[16]  L. Chauvelot‐Moachon,et al.  Technetium Tc 99m hexamethyl propylene amine oxine leukocyte scintigraphy in patients with ulcerative colitis: correlation with clinical, biologic, endoscopic, and pathologic intensity, and local release of interleukin 8. , 1998, Gastrointestinal endoscopy.

[17]  M. Thakur,et al.  A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime , 1998, European Journal of Nuclear Medicine.

[18]  W. Tindale,et al.  Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease , 1996, European journal of gastroenterology & hepatology.

[19]  F. Jewell,et al.  Technetium-99m-HMPAO labelled leucocytes in the detection and monitoring of inflammatory bowel disease in children. , 1996, British Journal of Radiology.

[20]  M. Giaffer.  Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications. , 1996, Gut.

[21]  C. Basile,et al.  Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance. , 1993, Gut.

[22]  W. Tindale,et al.  Quantification of disease activity in Crohn's disease by computer analysis of Tc-99m hexamethyl propylene amine oxime (HMPAO) labelled leucocyte images. , 1993, Gut.

[23]  L. Franzén,et al.  Do technetium-99m hexamethylpropylene amine oxime-labeled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis? , 1992, Scandinavian journal of gastroenterology.

[24]  J. Andrews,et al.  Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation. , 1991, Gut.

[25]  H. Schmidt,et al.  Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. , 1988, Gastroenterology.

[26]  S. Osman,et al.  Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. , 1988, Radiology.

[27]  C. Smith,et al.  Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. , 1986, Gut.

[28]  M. Gassull,et al.  111In-Oxine-labelled autologous leucocytes in inflammatory bowel disease: New scintigraphic activity index , 1986, European Journal of Nuclear Medicine.

[29]  J. Hunter,et al.  Evaluation of indium scintigraphy in patients with active inflammatory bowel disease. , 1984, Gut.

[30]  I. Mcdougall,et al.  Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. A prospective comparison study. , 1983, Gastroenterology.

[31]  A. Peters,et al.  Indium-111 autologous leucocyte scanning: comparison with radiology for imaging the colon in inflammatory bowel disease. , 1982, British medical journal.

[32]  L. Witts,et al.  Cortisone in Ulcerative Colitis , 1954 .

[33]  S. Truelove,et al.  Cortisone in Ulcerative Colitis , 1954 .